Evofem Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Evofem Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8% to $18,218,000. The net income raised on $52,979,000 and profit margin reached 291%. Total operating expenses were $27,772,000.
Profit Margin
| 2014 | 0 | -10.81M | |
|---|---|---|---|
| 2015 | 0 | -43.15M | |
| 2016 | 0 | -13.01M | |
| 2017 | 0 | -9.99M | |
| 2018 | 0 | -125.71M | |
| 2019 | 0 | -80.03M | |
| 2020 | 446K | -142.30M | -31907.85% |
| 2021 | 8.24M | -205.19M | -2488.99% |
| 2022 | 16.83M | -76.69M | -455.53% |
| 2023 | 18.21M | 52.97M | 290.81% |
EVFM Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 18.21M | 16.83M | 8.24M | 446K | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 6.51M | 4.41M | 4.05M | 468K | 905K | 0 | 244K | 0 | 58.42K | 0 |
Gross profit | 11.70M | 12.42M | 4.18M | -22K | -905K | 0 | -244K | 0 | -58.42K | 0 |
Operating exp. | ||||||||||
Research and development | 2.93M | 25.03M | 33.12M | 17.05M | 22.23M | 43.41M | 3.94M | 6.57M | 34.40M | 5.17M |
Selling and marketing | 11.66M | 43.95M | 113.15M | 56.46M | 10.12M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 27.77M | 96.54M | 170.99M | 103.60M | 52.74M | 77.64M | 10.04M | 12.04M | 42.04M | 9.59M |
Operating income | -17.84M | -84.12M | -166.80M | -103.62M | -52.74M | -77.64M | -10.04M | -12.04M | -42.04M | -9.59M |
Other income (expenses), net | 70.84M | 7.47M | -38.37M | -38.68M | -27.28M | -48.19M | -95.25M | -976.29K | -1.10M | -1.22M |
Income before tax | 52.99M | -76.65M | -205.17M | -142.30M | -80.02M | -125.71M | -9.99M | -13.01M | -43.15M | -10.81M |
Income tax expense | 17K | 44K | 17K | 4K | 4K | 2K | 51.25K | -9.62K | -32.39K | 357.22K |
Net income | 52.97M | -76.69M | -205.19M | -142.30M | -80.03M | -125.71M | -9.99M | -13.01M | -43.15M | -10.81M |
Earnings per share | ||||||||||
Basic EPS | 10.35 | -163.19 | -2.93K | -3.55K | -4.00K | -10.76K | -9.56K | -10.61K | -35.46K | -8.90K |
Diluted EPS | 0.05 | -163.19 | -2.93K | -3.55K | -4.00K | -10.76K | -9.56K | -10.61K | -35.46K | -8.90K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |